Delivery Order SPE2DB22D2206-SPE2DB25FEW11

Award Date 12/26/24
Potential Completion Date 1/17/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,005.84 firm fixed-price delivery order is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of January 20, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $5,504.81, is for the delivery of 4566677381 PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 2, 2025. The contract was awarded on December 10, 2024 and does not have a set-aside...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 contract is for the delivery of PHESGO 600-600 mg-20,000 unit 10 ml medical products. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award is between the Defense Logistics Agency (DLA) and AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,320.92 Firm Fixed Price Delivery Order contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 10, 2024. The award is a task order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,916.78 firm fixed price delivery order contract is for the supply of PHESGO 600-600 MG-20,000 unit 10ML, a medical product. The contract has a completion date of January 27, 2025 and was awarded on January 3, 2025. The award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $10,641.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of PHESGO, a medical product, with a completion date of October 7, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) vehicle between Amerisourcebergen and the DLA, potentially worth up to $999,999,999, for the supply of a broad range of medical...
The federal contract award SPE2DB22D3016|SPE2DB25FAHZ7 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,458.39 firm fixed-price delivery order covers the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product, with a period of performance through January 24, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,641.84 and is a firm fixed-price delivery order with a completion date of November 19, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $5,320.92 and a performance period through May 6, 2024. The contract is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
The federal contract award summarized here was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,105.26 firm fixed-price delivery order is for the supply of 30,000 units of the drug PHESGO (1,200-600mg 15ml), with an ultimate completion date of October 12, 2022. This award is a task order under AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEW11
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,009.64, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of January 17, 2025 and was awarded on December 26, 2024.

The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, does not have any major subcontractors listed for this particular award.

Generated 4/1/25, 3:43 PM